Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06045468
Other study ID # Kenevo2023
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 5, 2023
Est. completion date December 31, 2024

Study information

Verified date September 2023
Source Median
Contact Johannes Schröter, Dr. med.
Phone 0049611757811
Email johannes.schroeter@median-kliniken.de
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Treatment and rehabilitation after transfemoral amputation represents a challenging medical field, involving intersectoral parties. Although treatment guidelines exists, their implementation is difficult. This study is conducted to evaluate the need to practice these guidelines in order to gain best benefits for the patients. Focus is set of early inpatient rehabilitation and the role of a microprocessor-controlled prothesis (Kenevo, Ottobock).


Description:

Right after major surgeries, e.g. amputations, inpatient rehabilitation follows in Germany. Costs are covered by different insurances, like public or private health care insurances or German pension insurance. Usually, inpatient rehabilitation lasts for 3 weeks. But after some surgeries, like amputation, patients need more time to recover and fitting of a prosthesis takes additional time. Therefore guidelines state, that rehabilitation should take up to 6-8 weeks after major amputation. To provide evidence to these guidelines, we conducted this study. Patients' choice on rehabilitation clinic decides on their assignment to the study group or control group. Inpatient rehabilitation is monitored with outcomes measurements. 3 measurements are carried out in the study group within rehabilitational stay of around 6 weeks (admission - middle - discharge) and 2 measurements are carried out in the control group within rehabilitational stay of around 3 weeks (admission - discharge). After discharge from rehabilitation, assessment of patient reported outcome measurements is continued every 6 weeks for both groups. Follow-up phase ends with 24 weeks after admission to rehabilitation. For subanalysis, different prosthetic devices (non-microprocessor-controlled vs. microprocessor-controlled prosthesis) are compared.


Recruitment information / eligibility

Status Recruiting
Enrollment 125
Est. completion date December 31, 2024
Est. primary completion date December 31, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - inpatient rehabilitation stay after transfemoral amputation or knee disarticulation - anticipated K-level 1 or 2 - body weight no more than 125kg (authorized body weight for prosthetic device) - German speaking - able to give informed consent Exclusion Criteria: - non-German speaking - not able to give informed consent - body weight over 125kg

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Amputation-specialized rehabilitation
Study center; amputation-specialized unit within rehabilitation facility; fully practicing national guidelines
Non-amputation-specialized rehabilitation
Control clinics; treating some amputated patients each year but do not practice national guidelines or partially practicing national guidelines

Locations

Country Name City State
Germany MEDIAN Clinics Wiesbaden

Sponsors (3)

Lead Sponsor Collaborator
Median Otto Bock Healthcare Products GmbH, University Medical Center Mainz

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Prosthetic Limb User's Survey of Mobility (PLUS-M) Patient reported outcome measurement with 12 questions assessing mobility; reported as t-score, max. t-score: 65.7 As follow-up 24 weeks after admission to rehabilitation (around 18-21 weeks after discharge from rehabilitation)
Secondary Reintegration to normal living index (RNLI) Patient reported outcome measurement with 11 questions asking to patients' reintegration into daily life, reported as percentage As follow-up 24 weeks after admission to rehabilitation (around 18-21 weeks after discharge from rehabilitation)
Secondary EuroQol questionnaire (EQ-5D-5L) Patient reported outcome measurement assessing quality of life, reported as health utility, score, score 0-1 with 0 meaning lowest quality of life and 1 highest quality of life As follow-up 24 weeks after admission to rehabilitation (around 18-21 weeks after discharge from rehabilitation)
Secondary Falls Number of falls with prothesis As follow-up 24 weeks after admission to rehabilitation (around 18-21 weeks after discharge from rehabilitation)
Secondary Fear of falling indoor and outdoor fear of falling on a numeric rating scale (0-10) with 0 meaning no fear of falling and 10 meaning maximum fear of falling As follow-up 24 weeks after admission to rehabilitation (around 18-21 weeks after discharge from rehabilitation)
Secondary Locomotor capability index (LCI 5) Patient reported outcome measurement assessing patients' locomotor capability, 14 questions, results are categorized in 2 dimension: basic or advanced activities, maximum score is 28 points for each dimension As follow-up 24 weeks after admission to rehabilitation (around 18-21 weeks after discharge from rehabilitation)
Secondary Barthel Index Patient reported outcome measurement assessing patients' self care, 10 questions with maximum score of 100 points As follow-up 24 weeks after admission to rehabilitation (around 18-21 weeks after discharge from rehabilitation)
Secondary Timed Up and Go Test Functional outcome measurement, assessing patients' capability to walk, time needed to get up from a chair, walk 3 m, turn and walk 3 m back until sitting down again At admission to rehabilitation facility (if patients are already equipped with a prosthesis), after 3 weeks and after 6 weeks (discharge from rehabilitation) of inpatient rehabilitation stay
Secondary 6 minute walking test Patient walks back and forth 12 m for 6 minutes, distance in meter is recorded At admission to rehabilitation facility (if patients are already equipped with a prosthesis), after 3 weeks and after 6 weeks (discharge from rehabilitation) of inpatient rehabilitation stay
Secondary AMP-PRO Functional outcome measurement, amputated-specific, assesses different activities of daily life, max. score 43 points At admission to rehabilitation facility (if patients are already equipped with a prosthesis), after 3 weeks and after 6 weeks (discharge from rehabilitation) of inpatient rehabilitation stay
See also
  Status Clinical Trial Phase
Completed NCT06399471 - Personalizing MPK Prescription N/A
Completed NCT02564432 - Microbiome and Metagenome in Percutaneous Osseointegrated Prostheses (MMPOP)
Active, not recruiting NCT02891707 - Mobile Device Outcomes-based Rehabilitation Program N/A
Active, not recruiting NCT01725711 - Osseointegrated Prostheses for the Rehabilitation of Amputees N/A
Recruiting NCT05662982 - Sub-Ischial Socket for Transfemoral Amputation and Lower Mobility N/A
Recruiting NCT05925712 - Aerofit Post Market Investigation N/A
Completed NCT03296904 - The CYBERnetic LowEr-Limb CoGnitive Ortho-prosthesis Plus Plus, 1st Clinical Study N/A
Completed NCT02219230 - Use of Passive, Adaptive, and Active Prosthetic Knees in Persons With Unilateral, Transfemoral Amputation N/A
Completed NCT04023045 - Assist-Knee: Energy-Harvesting Knee Prosthesis N/A
Recruiting NCT05989243 - Improving Socket Fit in Female and Male Veterans With Transtibial and Transfemoral Amputation
Recruiting NCT05695911 - Transfemoral Osseointegrated Prosthesis Limb-Load Symmetry Training N/A
Recruiting NCT05831696 - Metabolic Cost of Walking With Passive vs. Powered Prosthetic Knees Among Persons With Limb Loss N/A
Completed NCT01537211 - Functional Outcomes in Dysvascular Transfemoral Amputees N/A
Recruiting NCT06218238 - A Biomechanical Evaluation of the Ossur Power Knee in Persons With Transfemoral Amputation N/A